期刊文献+

水飞蓟宾-磷脂酰胆碱复合物对肝损伤小鼠的保护作用 被引量:1

Protective Effect of Silybin-phosphatidylcholine Compound on Acute Hepatic Injury in Mice
下载PDF
导出
摘要 目的探讨水飞蓟宾-磷脂酰胆碱复合物(SPC)对异硫氰酸-α-萘酯(ANIT)所致小鼠急性肝损伤的保护作用。方法40只小鼠随机分成4组,每组10只:正常对照组、ANIT模型组、ANIT+SPC低剂量组(150mg/Kg)、ANIT+SPC高剂量组(300mg/Kg)。前两组给予0.5%羧甲基纤维素钠(CMC-Na)悬液灌胃,后两组分别给予SPC(150、300mg/Kg)CMC-Na悬液灌胃,连续1周。末次给予SPC2h后,正常对照组灌胃给予花生油,其它三组给予ANIT60mg/kg(花生油配制),造成小鼠急性肝损伤模型,16h(禁食不禁水12h)后摘眼球采血,分离血清,检测血清中丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、血清总胆红素(TB)。结果SPC明显降低造模小鼠血清中ALT、AST、TB值,SPC组与模型组比较差异显著(P<0.05)。结论SPC对ANIT造成的急性肝损伤有明显的保护作用。 Objective To observe the protective effect of silybin - phosphatidylcholine compound (SPC) on acute liver damage induced by alpha -naphthylisothiocyanate (ANIT) in mice. Methods Forty mice were randomly and equally divided into four groups: normal group, model group,SPC Ⅰ group, SPC Ⅱgroup. Intragastric administration of 0. 5% CMC -Na suspension were given to the normal and model group, and two quantities of SPC suspension ( 150mg/Kg and 300mg/Kg) were respectively given to SPC Ⅰ and SPC Ⅱgroups for one week. At 12h after last administration of SPC, all of groups besides normal were given ANIT ( dissolved in peanut oil, 60mg/kg) by lavage and the normal group just only were given peanut oil by the same volume and same way. After 16h of ANIT administration, the levels of serum alanine transferase ( ALT), aspartate aminotransferase ( AST), serum total bilirubin (TB) were detected by biochemical method. Results SPC could obviously decrease the heightened activities of serum ALT, AST and TB induced by ANIT( P 〈 0. 05). Conclusion SPC possess a protective role on ANIT- induced hepatie damage in mice.
出处 《医药论坛杂志》 2008年第10期20-21,共2页 Journal of Medical Forum
关键词 水飞蓟宾-磷脂酰胆碱复合物 异硫氰酸-α-萘酯 肝损伤 保护作用 Silybin - phosphatidylcholine compound(SPC) Alpha - naphthylisothiocyanate (ANIT) Liver damage Protective effect
  • 相关文献

参考文献5

二级参考文献17

  • 1陈大为,刘立民,丁玉芝,李三鸣,刘茜英.水飞蓟素(益肝灵)片剂溶出速率的研究 Ⅱ.水飞蓟素亲水辅料研磨混合物制备及溶出的研究[J].中成药,1993,15(5):2-4. 被引量:13
  • 2Flora K, Hahn M, Rose H, et al. Milk thistle (silybum marianum)for the therapy of liver disease[J]. Am J Gastroenterol, 1998,93(2): 139 - 143.
  • 3Luper S. A review of plants used in the treatment of liver disease:part 1[J]. Altern Med Rev, 1998,3(6) :410 - 412.
  • 4Flora K,Hahn M,Rose H,et al.Milk thistle(silybum marianum) for the therapy of live disease[J].Am J Gastroenterol,1998,93(2):139-143.
  • 5FloraK,HahnM,RoseH,etal.Milkthistle(Silybummarianum)forthetherapyofliverdisease[J].AmJGastroenterol,1998,93(2):139.
  • 6LuperS.Areviewofplantsusedinthetreatmentofliverdisease:part1[J].AltemMedRev,1998,3(6):410.
  • 7SkottovaN,KrecrnanV.Silymarinasapotentialhypocholesterolaemicdrug[J].PhysiolRes,1988,47(1):1.
  • 8deGrootH,RauenU.Tissueinjurybyreactiveoxygenspeciesandtheprotectiveeffectsofflavonoids[J].FundamClinPharmacol,1998,12(3):249.
  • 9BindoliA.Inhibitoryactionofsilymarinoflipidperoxideformationinratlivermitochondriaandmicrosomes[J].BiochemPharmacol,1977,26:2405.
  • 10KonyaL,KekesiV,NagyST,etal.Effectofantioxidanttreatmentonthemyocardiumduringreperfusionindogs[J].ActaPhysiolHung,1993,81(3):219.

共引文献41

同被引文献37

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部